# Uxin Ltd: Form 20-F for the period ended Mar 31, 2023

- Company: [Uxin Ltd](/companies/uxin.md) (CIK 1729173)
- Form: 20-F
- Filed: 2023-08-14
- Accepted by EDGAR: Aug 14, 2023, 16:23 ET
- Period: 2023-03-31
- Accession: 0000950170-23-042446
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1729173/000095017023042446/uxin-20230331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729173/000095017023042446/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2022-04-01 to 2023-03-31 | $299.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2022-04-01 to 2023-03-31 | $296.1m | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2022-04-01 to 2023-03-31 | $3.7m | us-gaap:GrossProfit |
| Research and development | 12 months, 2022-04-01 to 2023-03-31 | $5.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2022-04-01 to 2023-03-31 | −$52.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2022-04-01 to 2023-03-31 | $3.1m | us-gaap:InterestExpense |
| Income tax | 12 months, 2022-04-01 to 2023-03-31 | $53.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2022-04-01 to 2023-03-31 | −$20.0m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 12 months, 2022-04-01 to 2023-03-31 | 1,344,536,565 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2022-04-01 to 2023-03-31 | −$36.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-04-01 to 2023-03-31 | $4.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2023-03-31 | $13.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-03-31 | $41.0m | us-gaap:AssetsCurrent |
| Total assets | at 2023-03-31 | $104.6m | us-gaap:Assets |
| Current liabilities | at 2023-03-31 | $87.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-03-31 | $188.8m | us-gaap:Liabilities |
| Long-term debt | at 2023-03-31 | $42.5m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | at 2023-03-31 | $2.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2023-03-31 | −$185.4m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729173/000095017023042446/uxin-20230331.htm

Filed Aug 14, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-042446. Last ingested by Listed: Nov 3, 2026, 09:26 ET. No prices; not investment advice.